NEUROCRINE BIOSCIENCES INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Neurocrine Biosciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Neurocrine Biosciences Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $65M, a 31.9% decline year-over-year.
  • Neurocrine Biosciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $339M, a 92.3% increase year-over-year.
  • Neurocrine Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was $250M, a 61.6% increase from 2022.
  • Neurocrine Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was $155M, a 72.4% increase from 2021.
  • Neurocrine Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2021 was $89.6M, a 78% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $339M $65M -$30.5M -31.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $370M $43.4M +$120M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $250M $148M +$58.7M +66% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-09
Q3 2023 $191M $83.1M +$14.6M +21.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $176M $95.5M +$112M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $64M -$76.6M -$90.5M -651% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $155M $89M +$96.3M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-09
Q3 2022 $58.2M $68.5M +$46M +204% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $12.2M -$16.9M -$59.2M -140% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $71.4M $13.9M -$18.2M -56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $89.6M -$7.3M -$355M -102% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-09
Q3 2021 $445M $22.5M +$80.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $365M $42.3M -$37.3M -46.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $402M $32.1M -$5.3M -14.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $407M $348M +$314M +923% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-05
Q3 2020 $93.4M -$57.6M -$111M -207% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $205M $79.6M +$28.3M +55.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $177M $37.4M +$140M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $37M $34M +$15.9M +88.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-05
Q3 2019 $21.1M $53.8M +$3.04M +5.98% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-05
Q2 2019 $18M $51.3M +$57.2M Apr 1, 2019 Jun 30, 2019 10-K 2021-02-05
Q1 2019 -$39.2M -$102M -$60.3M -144% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-05
Q4 2018 $21.1M $18.1M +$11.2M +162% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-07
Q3 2018 $9.93M $50.8M +$61.9M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-07
Q2 2018 -$52M -$5.91M +$54.1M +90.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-07
Q1 2018 -$106M -$41.8M +$36.5M +46.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-07
Q4 2017 -$143M $6.89M +$51.6M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-08
Q3 2017 -$194M -$11.1M +$25.8M +69.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-08
Q2 2017 -$220M -$60M -$19.7M -48.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-08
Q1 2017 -$200M -$78.3M -$59.1M -307% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-08
Q4 2016 -$141M -$44.7M -$15.3M -52.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-13
Q3 2016 -$126M -$36.9M -$2.45M -7.12% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-13
Q2 2016 -$123M -$40.3M -$16.3M -67.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-13
Q1 2016 -$107M -$19.3M -$18.1M -1516% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-13
Q4 2015 -$88.9M -$29.3M -$9.87M -50.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-14
Q3 2015 -$79.1M -$34.4M -$18.6M -117% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-14
Q2 2015 -$60.5M -$24M -$10.6M -79.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-14
Q1 2015 -$49.9M -$1.19M +$10.7M +89.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-14
Q4 2014 -$60.5M -$19.4M -$8.8M -82.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-11
Q3 2014 -$51.7M -$15.9M -$4.74M -42.6% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-11
Q2 2014 -$47M -$13.4M -$1.14M -9.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-11
Q1 2014 -$45.9M -$11.8M +$233K +1.93% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-11
Q4 2013 -$46.1M -$10.6M -$20.1M -212% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-09
Q3 2013 -$26M -$11.1M -$8.05M -262% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-09
Q2 2013 -$17.9M -$12.2M -$11.7M -2344% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-09
Q1 2013 -$6.16M -$12.1M -$11.2M -1263% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-09
Q4 2012 $5.03M $9.49M +$8.16M +613% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-11
Q3 2012 -$3.13M -$3.08M -$34.5M -110% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-11
Q2 2012 $31.3M -$501K -$2.48M -125% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-11
Q1 2012 $33.8M -$886K -$3.77M -131% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-11
Q4 2011 $37.6M $1.33M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-08
Q3 2011 $31.4M +$28M +842% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-08
Q2 2011 $1.98M +$7.13M Apr 1, 2011 Jun 30, 2011 10-K 2013-02-08
Q1 2011 $2.88M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-08
Q3 2010 $3.33M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 -$5.15M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.